• Adveritas has received firm commitments for a Placement of 25 million fully paid ordinary shares at $0.08 each, raising $2 million before costs.
  • Bell Potter Securities is sole lead manager, with a fee of 1 per cent of funds raised stated in the Appendix 3B.
  • Proceeds are intended for new product features, Marketing to diversify the customer base and general working capital.

The placement

Adveritas Limited (ASX:AV1) announced on 15 October 2026 that it has received firm commitments from existing shareholders for a placement of 25 million fully paid ordinary shares at $0.08 each. That raises $2 million before costs, a figure that matches the company's own announcement and the arithmetic of 25 million shares at 8 cents. Bell Potter Securities Limited is sole lead manager to the placement. The Appendix 3B states that the lead manager fee is 1 per cent of the funds raised, with no other fees listed.

The new shares will rank equally with existing fully paid ordinary shares from their date of issue. The company expects settlement on or around Friday 23 October 2026, with issue and Quotation expected on Monday 26 October 2026, when it will lodge an Appendix 2A with ASX. The Appendix 3B itself lists 23 October 2026 as the issue date, so the two documents differ slightly on whether the shares are issued on the 23rd or the 26th. Readers should treat the dates as indicative.

Capacity and approvals

The shares are being issued under the company's available placement capacity under ASX Listing Rule 7.1, which the Appendix 3B records as the 15 per cent capacity. The notice says no security holder approval is required, and it does not indicate use of the additional 10 per cent capacity under Listing Rule 7.1A. The notice does not indicate an underwriter.

Pricing and the stated premium

The company's headline describes the placement as priced at a 42.9 per cent premium to the last close. In the announcement, it gives that last close as $0.058 on 14 October 2026, and also quotes a 27.6 per cent premium to the 30-day volume-weighted average price. The 30-day VWAP itself is not stated, so the second figure cannot be checked.

The first figure does not reconcile with the stated inputs. An issue price of $0.08 against a last close of $0.058 is a premium of about 37.9 per cent, not 42.9 per cent. A 42.9 per cent premium would correspond to a last close of about $0.056. The Appendix 3B does not give a last close price, so the discrepancy cannot be resolved from the documents reviewed. The company may clarify the figure in a later announcement.

Use of funds

Adveritas says it will use the proceeds in three areas. The first is the development and commercialisation of new product features. The second is marketing initiatives intended to diversify the company's customer base further. The third is general working capital. The announcement does not allocate the $2 million between these purposes, and it does not set out cash balances, Revenue or burn rates, so the placement's effect on the company's funding runway is not quantified in the documents.

Commercial implications

The company presents the participation of existing shareholders as support for its plans. Beyond the firm commitments described, the announcement does not name the participants, and the Appendix 3B's response on related-party participation is not clearly legible in the version reviewed. The placement will add 25 million shares to the share count, though the number of shares on issue before the placement is not given in the announcement.

Conditions and next steps

The announcement states firm commitments rather than conditions, and no Shareholder meeting is needed under the stated capacity. The confirmed milestones are settlement on or around 23 October 2026 and issue and quotation expected on 26 October 2026, with an Appendix 2A to follow. The raising funds product development and marketing intentions rather than reporting any commercial outcome, and the documents do not describe results from those activities.